|
⚲
|
| Keyboard |
| Evan Rachlin | |
|---|---|
| Firm | |
| Address | c/o Iambic Therapeutics, Inc 5627 Oberlin Drive, Suite 120 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Iambic Therapeutics Inc | 021-564708 | Director | 99.3 M of 125.0 M |
||
| Orsobio Inc | 021-522654 | Director | 40.0 M of 67.0 M |
||
| Cardurion Pharmaceuticals Inc | 021-519629 | Director | 260.4 M of 260.4 M |
||
| Ascenta Capital Project Ikigai SPV LP | 021-518334 | Executive Officer | 5.6 M of 5.6 M |
||
| Iambic Therapeutics Inc | 021-511607 | Director | 38.4 M of 50.0 M |
||
| Ascenta Capital Project Argos SPV LP | 021-495510 | Executive Officer | 1.2 M of 1.2 M |
||
| Iambic Therapeutics Inc | 021-494624 | Director | 103.2 M of 110.0 M |
||
| Ascenta Capital Project Turing SPV LP | 021-493164 | Executive Officer | 0.8 M of 0.8 M |
||
| Ascenta Capital Management Co LP | |||||
| Ascenta Capital Project Henri SPV LP | 021-524392 | Executive Officer | 2.0 M of 2.0 M |
2.0 M | |
| Ascenta Capital Project Ikigai SPV LP | 021-524392 | Executive Officer | 2.0 M of 2.0 M |
5.6 M | |
| Ascenta Capital Fund I LP | 021-482539 | Executive Officer | 228.0 M of 350.0 M |
325.1 M | |
| Ascenta Capital SPV I LP | 021-471612 | Executive Officer | 15.0 M of 15.0 M |
||